TCT-59 Surgical Aortic Valve Deterioration: Time to Redo-SAVR in Trifecta Versus Non-Trifecta Valves
Luai Madanat(Corewell Health), Amr E. Abbas(Oakland University), Simon Dixon(Beaumont Hospital, Royal Oak), Brian Renard(Beaumont Hospital, Troy), Jeffrey Altshuler(Beaumont Hospital, Royal Oak), Elvis Cami(Beaumont Health), Bogdan A. Kindzelski(Beaumont Hospital, Royal Oak), Richard Bloomingdale(Oakland University), Ivan Hanson(Beaumont Hospital, Royal Oak), Shailesh Niroula(Beaumont Hospital, Troy), Franco Fazzalari(Oakland University), Mazhed Kheyrbek(Beaumont Hospital, Troy), Rohit Chandra(Beaumont Hospital, Troy), Alessandro Vivacqua(Beaumont Hospital, Royal Oak)
Cited by 0
Related Papers
Impact of COVID‐19 pandemic on STEMI care: An expanded analysis from the United States
|Catheterization and Cardiovascular Interventions|2020|92
Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience
|American Heart Journal|2015|65
Modern practice and outcomes of reoperative cardiac surgery
|Journal of Thoracic and Cardiovascular Surgery|2021|54
Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery
|Perfusion|2017|53
Serious Gastrointestinal Complications After Cardiac Surgery and Associated Mortality
|The Annals of Thoracic Surgery|2020|38